BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23532410)

  • 1. Cyanobacteria: potential candidates for drug discovery.
    Dixit RB; Suseela MR
    Antonie Van Leeuwenhoek; 2013 May; 103(5):947-61. PubMed ID: 23532410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive secondary metabolites from marine microbes for drug discovery.
    Nikapitiya C
    Adv Food Nutr Res; 2012; 65():363-87. PubMed ID: 22361200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyanobacteria: an emerging source for drug discovery.
    Singh RK; Tiwari SP; Rai AK; Mohapatra TM
    J Antibiot (Tokyo); 2011 Jun; 64(6):401-12. PubMed ID: 21468079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive natural products from marine cyanobacteria for drug discovery.
    Tan LT
    Phytochemistry; 2007 Apr; 68(7):954-79. PubMed ID: 17336349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical agents from filamentous marine cyanobacteria.
    Tan LT
    Drug Discov Today; 2013 Sep; 18(17-18):863-71. PubMed ID: 23711931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifouling potential of cyanobacteria: a mini-review.
    Dahms HU; Ying X; Pfeiffer C
    Biofouling; 2006; 22(5-6):317-27. PubMed ID: 17110355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polar microorganisms, a potential source for new natural medicines--a review].
    Zeng Y; Chen B; Zou Y; Zheng T
    Wei Sheng Wu Xue Bao; 2008 May; 48(5):695-700. PubMed ID: 18652306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of cyanobacteria in biotechnology.
    Abed RM; Dobretsov S; Sudesh K
    J Appl Microbiol; 2009 Jan; 106(1):1-12. PubMed ID: 19191979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodiscovery from rare actinomycetes: an eco-taxonomical perspective.
    Kurtböke DI
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):1843-52. PubMed ID: 22297430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotechnological Applications of Bioactive Peptides From Marine Sources.
    Giordano D; Costantini M; Coppola D; Lauritano C; Núñez Pons L; Ruocco N; di Prisco G; Ianora A; Verde C
    Adv Microb Physiol; 2018; 73():171-220. PubMed ID: 30262109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole Alkaloids of the Stigonematales (Cyanophyta): Chemical Diversity, Biosynthesis and Biological Activity.
    Walton K; Berry JP
    Mar Drugs; 2016 Apr; 14(4):. PubMed ID: 27058546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyanobacteria as a source of natural products.
    Welker M; Dittmann E; von Döhren H
    Methods Enzymol; 2012; 517():23-46. PubMed ID: 23084932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic and antimitotic activities in aqueous extracts of eight cyanobacterial strains isolated from the marine sponge Petrosia ficiformis.
    Pagliara P; Caroppo C
    Toxicon; 2011 May; 57(6):889-96. PubMed ID: 21396391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications.
    Khalifa SAM; Shedid ES; Saied EM; Jassbi AR; Jamebozorgi FH; Rateb ME; Du M; Abdel-Daim MM; Kai GY; Al-Hammady MAM; Xiao J; Guo Z; El-Seedi HR
    Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33923369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoughts and facts about antibiotics: where we are now and where we are heading.
    Bérdy J
    J Antibiot (Tokyo); 2012 Aug; 65(8):385-95. PubMed ID: 22511224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic targets and the role of technology in developing novel cannabinoid drugs from cyanobacteria.
    Vijayakumar S; Manogar P; Prabhu S
    Biomed Pharmacother; 2016 Oct; 83():362-371. PubMed ID: 27416557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotechnological and industrial significance of cyanobacterial secondary metabolites.
    Rastogi RP; Sinha RP
    Biotechnol Adv; 2009; 27(4):521-39. PubMed ID: 19393308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanobacterial bioactive molecules--an overview of their toxic properties.
    Jaiswal P; Singh PK; Prasanna R
    Can J Microbiol; 2008 Sep; 54(9):701-17. PubMed ID: 18772933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.
    Tan LT; Phyo MY
    Molecules; 2020 May; 25(9):. PubMed ID: 32397127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products isolation in modern drug discovery programs.
    Gray AI; Igoli JO; Edrada-Ebel R
    Methods Mol Biol; 2012; 864():515-34. PubMed ID: 22367910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.